Related Papers
Associated Asia Research Foundation (AARF) NURSE'S KNOWLEDGE REGARDING MANAGEMENT OF ECLAMPSIA AT SELECTED PRIVATE HOSPITAL IN BANGLADESH
Ratna Khatun, Faisal Muhammad
Introduction: Eclampsia affects 5 to 10% of all pregnancies and contributes to 10 to 15% of maternal deaths worldwide. Estimated case fatality rate due to eclampsia is 14 times higher in developing countries compared to developed countries. Eclampsia is a potentially fatal disorder of pregnant women that has been prevalent since the time of Hippocrates; it remains an important cause of maternal mortality throughout the world, accounting for about 50,000 deaths worldwide. This study was aimed to assess the level of nurse’s knowledge regarding management of eclampsia. Materials and Methods: A descriptive cross-sectional study was carried out from September 2016 to January 2017. A total of 105 nurses were selected purposively during the period of this study, the data was collected using self-administered semi-structured questionnaire and it was analysed using SPSS version 20.0. Results: In this study the mean of the respondents was 31.6 years. Slightly above half (51.4%) of the respondents were unmarried and the rest of them were married. Majority of the participants (52.5%) had B.Sc. nursing; however 70.5% of the respondents knew about the current management of Eclampsia. Conclusion: The findings of this study revealed that the majority of the nurses that participated in this study had somehow enough level of knowledge about the management of eclampsia. However it has been observed that the nurses had some lapses regarding the knowledge on drugs use in the management of eclampsia.
PubMed
Magnesium sulphate in the prophylaxis and treatment of eclampsia
2004 •
Shehla Noor
Background: Magnesium Sulphate is considered to be the agent of choice for the control of eclamptic seizures in pregnant women. Our objectives were to determine frequency of eclampsia and pre-eclampsia in our unit and to determine the effect of initial loading dose of magnesium sulphate on maternal and fetal outcome. Methods: This study was carried out in Department of Gynaecology at Lady Reading Hospital, Peshawar. In the year 2000 only 133 patients received magnesium sulphate out of 228 cases of eclampsia and pre eclampsia due to the problems with the continuous supply of the drug. This included 53 cases of eclampsia and 80 cases of pre-eclampsia. Information regarding the dosage of magnesium sulphate labor out come, maternal and fetal outcome, side effects and complications of therapy were evaluated from hospital case records. The magnesium sulphate regimen consisted of 4 gm loading dose as 20% solution intravenously over 10-15 minutes followed immediately by 5 gm into each buttock. Dose of 5 gm intramuscularly was repeated only if the patient developed convulsions. Results: Eclampsia and pre-eclampsia occurred in 1 in 25.5 and 1 in 34.4 deliveries respectively. Majority of patients received the initial loading dose of magnesium sulphate, but in 2 patients' dose had to be repeated. In two patients of pregnancy induced hypertension convulsions occurred soon after delivery unheralded by any signs and symptoms of impending eclampsia. Perinatal mortality was 19 (35.8%) and 16 (20%) in eclampsia and pre-eclampsia respectively. High perinatal mortality was attributed to prematurity as only 16.98% of eclampsia and 57.5% of pre-eclampsia were more than 37 weeks. One patient of severe pre-eclampsia developed postpartum hemorrhage and acute renal failure, but she recovered while another one developed sudden postpartum collapse immediately after delivery and died due to cerebrovascular accident. 8 patients of eclampsia died despite intensive management. All of them were referred from periphery with history of multiple fits and were brought in a serious state. Conclusion: Frequency of eclampsia and pre-eclampsia is high in this region with high perinatal and maternal morbidity and mortality. Magnesium sulphate is an effective drug to prevent and control seizures. It is easy to administer and subsequent nursing is easy. Seizures usually terminate after the initial loading dose of magnesium sulphate.
Maternite
pierre marie medor
Evaluation of knowledge and management practices of hypertension in pregnancy among health care workers in Moshi urban, Tanzania
2012 •
JOY NDIFE
TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH
Maternal and Health System Predictors of Preeclampsia among Pregnant Women Attending Health Care Facilities in Lusaka, Zambia: A Retrospective Cohort Study
2021 •
Pamela Mwansa
Preeclampsia (PE) Is The Leading Cause Of Maternal And Perinatal Morbidity/Mortality. A Study In Lusaka Estimated Preeclampsia/Eclampsia Prevalence At 18.9%. The Aim Of The Study Was To Determine The Health System And Maternal Predictors Of Preeclampsia Among Pregnant Women Attending Public Health Facilities (HF) In Lusaka, Zambia. This Is A 12months Retrospective Cohort Study. Records Of 770 Pregnant Women During Antenatal Care Between January To December 2020 From Five HFs In Lusaka Were Reviewed And Classified Into With Or Without PE. The Risk Factors For PE Were ed From The Records. Descriptive Analysis And Inferential Statistics Were Determined. The Respondents Were Aged 18-40years With Mean Age Of 27.09 Years And SD±5.1. Age 25- 32 Years Accounted For 344 (45%), Married 250 (82%), 346 (45%) Had Secondary School Education And 293 (38%) Had Parity Of 2. Significant Differences Were Observed In The Administration Of Magnesium Sulphate And Oxygen For Severe Preeclampsia (P = 0.001...
The Global Library of Women's Medicine
Preventing Pre-eclampsia and its Complications
Joaquin Jaime
Best Practice & Research Clinical Obstetrics & Gynaecology
Pre-eclampsia in low and middle income countries
2011 •
James Roberts
Open Access Journal of Reproductive System and Sexual Disorders
The Study of Magnesium sulphate vs Diazepam in Eclampsia
2018 •
aisha malik
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC
Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project
2012 •
Peter Von Dadelszen, Marianne Vidler
The hypertensive disorders of pregnancy, in particular preeclampsia, matter because adverse events occur in women with preeclampsia and, to a lesser extent, in women with the other hypertensive disorders. These adverse events are maternal, perinatal, and neonatal and can alter the life trajectory of each individual, should that life not be ended by complications. In this review we discuss a number of priorities and dilemmas that we perceive to be facing health services in low and middle income countries as they try to prioritize interventions to reduce the health burden related to preeclampsia. These priorities and dilemmas relate to calcium for preeclampsia prevention, risk stratification, antihypertensive and magnesium sulphate therapy, and mobile health. Significant progress has been and is being made to reduce the impact of preeclampsia in low and middle income countries, but it remains a priority focus as we attempt to achieve Millennium Development Goal 5.
BMC pregnancy and childbirth
Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil
2016 •
Fátima Lotufo
Eclampsia is the main cause of maternal death in Brazil. Magnesium sulfate is the drug of choice for seizure prevention and control in the management of severe preeclampsia and eclampsia. Despite scientific evidence demonstrating its effectiveness and safety, there have been delays in managing hypertensive disorders, including timely access to magnesium sulfate. To conduct a general situational analysis on availability and use of magnesium sulfate for severe preeclampsia and eclampsia in the public health system. A situational analysis was conducted with two components: a documental analysis on information available at the official websites on the policy, regulation and availability of the medication, plus a cross sectional study with field analysis and interviews with local managers of public obstetric health services in Campinas, in the southeast of Brazil. We used the fishbone cause and effect diagram to organize study components. Interviews with managers were held during field o...
